Your browser doesn't support javascript.
loading
Toward robust clinical genome interpretation: Developing a consistent terminology to characterize Mendelian disease-gene relationships-allelic requirement, inheritance modes, and disease mechanisms.
Roberts, Angharad M; DiStefano, Marina T; Riggs, Erin Rooney; Josephs, Katherine S; Alkuraya, Fowzan S; Amberger, Joanna; Amin, Mutaz; Berg, Jonathan S; Cunningham, Fiona; Eilbeck, Karen; Firth, Helen V; Foreman, Julia; Hamosh, Ada; Hay, Eleanor; Leigh, Sarah; Martin, Christa L; McDonagh, Ellen M; Perrett, Daniel; Ramos, Erin M; Robinson, Peter N; Rath, Ana; Sant, David W; Stark, Zornitza; Whiffin, Nicola; Rehm, Heidi L; Ware, James S.
  • Roberts AM; National Heart and Lung Institute and MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom; Dept of Medical Genetics, Great Ormond Street Hospital, Great Ormond Street, London, United Kingdom. Electronic address: angharad.roberts@imperial.ac.uk.
  • DiStefano MT; Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Riggs ER; Geisinger Autism and Developmental Medicine Institute, Danville, PA.
  • Josephs KS; National Heart and Lung Institute and MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom; Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Alkuraya FS; Department of Translational Genomics, Center for Genomic Medicine, KFSHRC, Riyadh, Saudi Arabia.
  • Amberger J; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Amin M; INSERM, US14-Orphanet, Paris, France.
  • Berg JS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Cunningham F; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
  • Eilbeck K; Department of Biomedical Informatics, University of Utah, Salt Lake City, UT.
  • Firth HV; Dept of Medical Genetics, Cambridge University Hospitals, Cambridge, United Kingdom; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
  • Foreman J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
  • Hamosh A; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Hay E; Dept of Medical Genetics, Great Ormond Street Hospital, Great Ormond Street, London, United Kingdom.
  • Leigh S; Genomics England, Queen Mary University of London, Dawson Hall, London, United Kingdom.
  • Martin CL; Geisinger Health System, Danville, PA.
  • McDonagh EM; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom; Open Targets, Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
  • Perrett D; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
  • Ramos EM; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
  • Robinson PN; The Jackson Laboratory for Genomic Medicine, Farmington, CT.
  • Rath A; INSERM, US14-Orphanet, Paris, France.
  • Sant DW; Department of Biomedical Informatics, University of Utah, Salt Lake City, UT.
  • Stark Z; Australian Genomics, Melbourne 3052, Australia; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne 3052, Australia; University of Melbourne, Melbourne 3052, Australia.
  • Whiffin N; Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; Big Data Institute and Wellcome Centre for Human Genetics, University of Oxford, United Kingdom.
  • Rehm HL; Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
  • Ware JS; National Heart and Lung Institute and MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom; Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA; Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Lon
Genet Med ; 26(2): 101029, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37982373
ABSTRACT

PURPOSE:

The terminology used for gene-disease curation and variant annotation to describe inheritance, allelic requirement, and both sequence and functional consequences of a variant is currently not standardized. There is considerable discrepancy in the literature and across clinical variant reporting in the derivation and application of terms. Here, we standardize the terminology for the characterization of disease-gene relationships to facilitate harmonized global curation and to support variant classification within the ACMG/AMP framework.

METHODS:

Terminology for inheritance, allelic requirement, and both structural and functional consequences of a variant used by Gene Curation Coalition members and partner organizations was collated and reviewed. Harmonized terminology with definitions and use examples was created, reviewed, and validated.

RESULTS:

We present a standardized terminology to describe gene-disease relationships, and to support variant annotation. We demonstrate application of the terminology for classification of variation in the ACMG SF 2.0 genes recommended for reporting of secondary findings. Consensus terms were agreed and formalized in both Sequence Ontology (SO) and Human Phenotype Ontology (HPO) ontologies. Gene Curation Coalition member groups intend to use or map to these terms in their respective resources.

CONCLUSION:

The terminology standardization presented here will improve harmonization, facilitate the pooling of curation datasets across international curation efforts and, in turn, improve consistency in variant classification and genetic test interpretation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Pruebas Genéticas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Pruebas Genéticas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article